Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,460,114
+$252,312 QoQ
Shares Held
29,374
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,296
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWE & RUSLING INC holds $48,551,537 across 10 Drug Manufacturers - General names. JNJ ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
97,901 | $24,635,807 | |
| 2 | AZN |
Astrazeneca PLC
|
42,193 | $8,000,635 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
29,374 | $7,460,114 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,744 | $3,179,604 | |
| 5 | AMGN |
Amgen Inc
|
4,998 | $1,809,875 | |
| 6 | LLY |
ELI LILLY & Co
|
1,076 | $1,290,586 | |
| 7 | PFE |
Pfizer Inc
|
35,247 | $848,747 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,437 | $686,910 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,460,114 | 29,374 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,207,802 | 29,487 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,206,430 | 29,990 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,980,967 | 21,470 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,970,987 | 19,450 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,838,532 | 23,146 | Shares | Sole | 2025-06-17 | |
| 2024-12-31 | $3,462,347 | 23,941 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $12,693,997 | 78,329 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $11,422,550 | 78,151 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,475,654 | 78,865 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,407,542 | 104,680 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $20,172,272 | 129,517 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $24,147,050 | 145,886 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,711,710 | 165,882 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,532,523 | 167,181 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $26,175,826 | 160,234 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $28,323,495 | 159,560 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,034,555 | 146,897 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $25,177,911 | 147,179 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,156,984 | 131,003 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,431,356 | 130,092 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $21,678,915 | 131,907 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $21,536,508 | 136,844 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $20,458,940 | 137,419 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $19,721,388 | 140,236 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $18,838,922 | 143,666 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||